Related Experiment Video
Updated: Jul 27, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
[Recurrent Candida sepsis with prolonged respiratory failure and severe liver dysfunction]
J Lewejohann1, M Hansen, C Zimmermann
1Klinik für Chirurgie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, D-23538 Lübeck, Germany. jlewejohann@t-online.de
Abstract:
Systemic mycoses, especially pulmonary diseases and septicemia are observed increasingly at intensive care units. Essential risk factors for development of candidosis are the expanded use of antibiotics and immunocompromised patients, caused either as a result of a severe underlying disease or iatrogenically induced after organ transplantation. Candida albicans is the most frequent pathogen in microbiological findings. Blood cultures are only positive in massive fungemia. We report a 50-year-old patient with recurrent Candida-septicemia: rupture of the distal esophagus after dilatation because of cardiac achalasia with mediastinal emphysema and mediastinitis. Severe acute respiratory distress syndrome after aspiration with septic shock and acute renal failure at the beginning. Long-term mechanical ventilation, continuous renal replacement therapy and multifarious antibiotic therapy. Early microbiological samples of several positive blood cultures and bronchoalveolar lavages revealed the presence of Candida albicans. In the further clinical course, detection of Pseudomonas species in bronchoalveolar lavages and Staphylococci as well as Enterococci in a number of positive blood cultures. Later on development of a severe liver dysfunction with test results that showed an intrahepatic cholestasis. Because of coagulation failure commencement of artificial liver support with the MARS-system (molecule adsorbent recirculating system). Decrease of high bilirubin levels was accompanied by improvement of clinical condition of the patient. In the following course, repeated severe systemic infections with phases of septicemia or rather septic shock and detection of Candida in several positive blood cultures and bronchoalveolar lavages. In each case increasing bilirubin levels with signs of intrahepatic cholestasis and each time improvement with antimycotic therapy (voriconazol, caspofungin and fluconazol). The patient showed more and more signs of immunodeficiency in the sequel. The clinical appearance of candidosis is manifold. Systemic Candida infections are frequent in patients with immunodeficiency. A recurrent Candida septicemia with prolonged respiratory failure and severe liver dysfunction in form of cholestatic hepatosis, that improved several times with antimycotic therapy in combination with evidence based intensive care measures and artificial organ support is a comparatively rare event.
Insights
Recurrent Candida septicemia in an intensive care unit patient with severe liver dysfunction improved with antifungal therapy and artificial organ support. This case highlights rare systemic Candida infections in immunocompromised individuals.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Hepatology
Background:
- Systemic mycoses, particularly candidemia, are increasing in intensive care units (ICUs).
- Risk factors include broad-spectrum antibiotic use and immunocompromised states, often seen post-transplantation or with severe illness.
- Candida albicans is a common pathogen, though blood cultures are often negative unless fungemia is massive.
Observation:
- A 50-year-old patient experienced recurrent Candida septicemia following esophageal rupture, leading to mediastinitis, acute respiratory distress syndrome, septic shock, and acute renal failure.
- The patient required prolonged mechanical ventilation, continuous renal replacement therapy, and broad antibiotic treatment.
- Subsequent complications included severe intrahepatic cholestasis and recurrent systemic infections with various pathogens, including Candida species.
Findings:
- Early cultures confirmed Candida albicans, with later detection of Pseudomonas, Staphylococci, and Enterococci.
- Artificial liver support (MARS-system) improved high bilirubin levels and the patient's clinical condition.
- Recurrent Candida septicemia episodes correlated with rising bilirubin levels and cholestatic hepatosis, consistently improving with antimycotic therapy (voriconazole, caspofungin, fluconazole).
Implications:
- This case illustrates a rare instance of recurrent Candida septicemia with prolonged respiratory failure and severe cholestatic hepatosis.
- Effective management involved a combination of evidence-based intensive care, artificial organ support, and targeted antimycotic therapy.
- The patient exhibited progressive immunodeficiency, underscoring the complexity of managing systemic Candida infections in critically ill, immunocompromised patients.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Acute Respiratory Failure-III
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Cryptococcal Meningitis
Candidiasis

